Bixiye
P10-16 New Drug-Related Prior Authorization Criteria for Gattex
Taariikhda uu dhaqangalayo Barnaamijka: 08, Feb 2016
Natiijooyinka Raadinta
Soo bandhiga 2791 - 2800 ee natiijooyinka 4229
Bixiye
P16-16 Blue Cross Contracts with SecureCare to Manage the Chiropractic Network
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 22, 2016
Bixiye
P4-16 New Drug-Related Prior Authorization Criteria for Myalept
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2016
Bixiye
P33-16 New Drug-Related Prior Authorization Criteria with Quantity Limit for Northera
Taariikhda dhaqangalka Barnaamijka: Jul 27, 2016
Bixiye
P11-16 New Drug-Related Prior Authorization Criteria: Idiopathic P ulmonary Fibrosis Prior Authorization with Quantity Limit Criteria: Esbriet ® and Ofev ®
Taariikhda uu dhaqangalayo Barnaamijka: 08, Feb 2016
Bixiye
P50-17 Provider Data Accuracy and Identified Lack of Claim Submissions
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 25, 2017
Bixiye
P30-16 New Prior Authorization Requirement for Lyme Disease: Diagnostic Testing and Intravenous Antibiotic Therapy
Taariikhda dhaqangalka Barnaamijka: Jul 07, 2016
Bixiye
P14-16 Addition of Lazanda ® to Existing Drug-Related Prior Authorization with Quantity Limit Program
Taariikhda uu dhaqangalayo Barnaamijka: Mar 29, 2016
Bixiye
P49-16 New Drug-Related Prior Authorization Criteria with Quantity Limit for Zavesca
Taariikhda uu dhaqangalayo barnaamijka: Okt 27, 2016
Bixiye
P24-16 Providers will see a change in our Prior Authorization Process for Government Products
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2016